Mobile

A study to evaluate the safety and efficacy of PF-06650833 in subjects with moderate to severely active rheumatoid arthritis who have an incomplete response to methotrexate treatment Estudio par...

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-002337-30

A study to evaluate the safety and efficacy of PF-06650833 in subjects with moderate to severely active rheumatoid arthritis who have an incomplete response to methotrexate treatment Estudio para evaluar la eficacia y seguridad de PF-06650833 en sujetos con artritis reumatoide de moderada a severa que han presentado una respuesta inadecuada a metotrexato (MTX)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of PF-06650833 at 12 weeks, in subjects with moderate - severe active RA who have had an inadequate response to methotrexate. Evaluar la eficacia de PF-06650833 a las 12 semanas, en sujetos con AR active moderada-severa con inadecuada respuesta a metotrexato.

Critère d'inclusion

  • Rheumatoid Arthritis,Aritritis reumatoide

Liens